Johnson & Johnson boasts a vast portfolio and a rock-solid balance sheet. AbbVie's main growth pillars are posting impressive ...

Working with mental health advocates and Mental Health America, the “Generation Fine” project “highlights the unique ...

It's hard to argue against its reliability.

New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.

A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD ...

Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s presentation. Going forward, the conglomerate’s Ethicon, DePuy Synthes, Biosense ...

Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els ...

Johnson & Johnson (NYSE:JNJ) today announced results from the first clinical study of its investigational Ottava surgical ...

Three name-brand diabetes drugs and a blood thinner are now available at a discount on the government platform and J&J's own ...

Add Yahoo as a preferred source to see more of our stories on Google. On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked ...

Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration's ...

On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one ...